Lowe’s Launches Affordable $99/Year HomeCare+ Subscription for Essential Home Maintenance

Lowe’s associate in red vest performing home maintenance service like replacing an air filter as part of the new HomeCare+ subscription program

Lowe’s has rolled out HomeCare+, a new $99 annual subscription for MyLowe’s Rewards members that provides two in-home visits per year, each allowing up to seven essential maintenance services performed by trained Lowe’s store associates. The program targets busy homeowners seeking reliable, affordable help with routine tasks like dryer vent cleaning, filter replacements, and safety … Read more

Balchem’s New T.E.A.M. Platform: Reframing the Data Advantage Narrative for Investors (BCPC)?

Balchem Corporation logo with digital agriculture icons representing plant tissue analysis and nutrient recommendations on a farm background

“Balchem Corporation’s recent launch of the Metalosate® T.E.A.M.™ digital platform represents a strategic pivot toward data-driven precision in its Plant Nutrition segment. By digitizing decades of proprietary research into an accessible tool for agronomists and advisors, the company strengthens its competitive moat in specialty crop micronutrients, potentially boosting advisor adoption, recurring revenue through Metalosate sales, … Read more

Why Used EVs May Be the Answer for Americans Looking for Affordable Cars

A row of used electric vehicles for sale at a dealership lot, showcasing affordable options for American buyers

“In today’s market, used electric vehicles offer a compelling path to affordability for American buyers. With average prices dropping significantly—often to around $27,800 to $34,000 for many models—used EVs now frequently cost less upfront than comparable used gas cars or sit close in price while delivering substantial long-term savings on fuel and maintenance. A surge … Read more

Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide® May Reduce Leptomeningeal Metastases Healthcare Costs by 40%

Medical illustration of cerebrospinal fluid analysis for leptomeningeal metastases detection using advanced assay technology.

“A new health economics analysis from Plus Therapeutics reveals that the CNSide® cerebrospinal fluid assay could slash overall healthcare costs related to leptomeningeal metastases by approximately 40% (ranging from 33% to 47%) through earlier detection, more precise treatment decisions, fewer hospitalizations, and better patient management. The study underscores the heavy economic burden of late-stage LM … Read more

Lodge Accommodations in Yellowstone: Travel Expert Larry King Spotlights Authentic Lodge Stays in HelloNation

Rustic log lodge exterior in Yellowstone National Park with surrounding pine trees and mountain views

“Staying in authentic lodges near Yellowstone offers travelers an unmatched connection to the park’s wild spirit—rustic charm, proximity to nature’s wonders, and a sense of place that chain hotels simply can’t replicate. Travel expert Larry King emphasizes that these stays immerse visitors in the true essence of the American West.” Yellowstone Lodge Accommodations: Insights from … Read more

Elon Musk’s X Money Debit Card Spotted In Action In New Payment Video

Metal X Money debit card being tapped on a payment terminal during a real transaction at a gas station convenience store

“A real-world transaction video shared by an X user demonstrates the X Money debit card in use at a retail location, marking a tangible step forward for Elon Musk’s vision of turning the platform into a comprehensive financial hub. The metal card, featuring personalized details, successfully processed a purchase, highlighting attractive perks like high-yield interest … Read more

Dyne Therapeutics Advances Rare Disease Pipeline With Pivotal Trials And Data

Dyne Therapeutics laboratory researchers analyzing neuromuscular disease data for rare disease pipeline advancement

Dyne Therapeutics is making significant strides in treating genetically driven neuromuscular diseases, highlighted by positive long-term cardiopulmonary data from the Phase 1/2 DELIVER trial of z-rostudirsen in Duchenne muscular dystrophy (DMD), the initiation of the pivotal Phase 3 HARMONIA trial for z-basivarsen in myotonic dystrophy type 1 (DM1), and ongoing registrational efforts supporting potential accelerated … Read more

Sir Nick Clegg Joins Efekta Education Group’s Advisory Board in Major EdTech Boost

Sir Nick Clegg, former UK Deputy Prime Minister, appointed to Efekta Education Group's Advisory Board for AI-powered learning innovation

In a significant move for the intersection of policy, technology, and education, former UK Deputy Prime Minister Sir Nick Clegg has been appointed to the Advisory Board of Efekta Education Group, an innovative AI-powered learning platform tackling global teacher shortages and educational inequities. This appointment comes as Efekta expands rapidly with large-scale deployments in regions … Read more

Nebius Group: Where Will It Be in 5 Years?

Futuristic AI data center with glowing Nvidia GPU clusters and high-density server racks representing Nebius Group's infrastructure expansion

Nebius Group, the Amsterdam-based AI cloud infrastructure provider, has exploded onto the scene with explosive revenue growth, major partnerships including a $2 billion investment from Nvidia, and ambitious expansion plans. By 2031, the company could emerge as a leading hyperscale AI utility, potentially achieving tens of billions in annual revenue and a multi-hundred-billion-dollar market cap … Read more

Silvaco Group Inc (SVCO) Q4 2025 Earnings: What Investors Should Anticipate

Stock chart and financial data overlay for Silvaco Group Inc (SVCO) Q4 2025 earnings anticipation

“Silvaco Group Inc (SVCO), a key player in TCAD, EDA software, and semiconductor IP solutions, is set to report its Q4 2025 results on March 12, 2026. Analysts anticipate revenue around $16-17 million amid ongoing growth in bookings, though persistent losses are expected with EPS near -$0.12. Investors will watch for signs of narrowing losses, … Read more